Search results
Waystar Holding Prices 45M Share IPO at $21.50/sh By Investing.com
Investing.com· 7 days agoWaystar granted the underwriters in the offering a 30-day option to purchase up to an additional...
25 Reasons to Buy Nvidia Stock Now
Motley Fool via Yahoo Finance· 4 days agoNvidia (NASDAQ: NVDA) stock has been a superb performer over the short and long terms. The artificial intelligence (AI) chip leader held its initial <...
Hong Kong Pop Star-Backed Esports Firm NIP Group Files for US IPO
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- NIP Group Inc., an esports company that counts Hong Kong singer Jackson Wang among...
Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the Second Quarter of 2024
Morningstar· 10 hours agoTrinity Capital Inc. (Nasdaq: TRIN) ("Trinity Capital" or the "Company"), a leading provider of diversified financial solutions to growth stage companies, today announced ...
Trump Media Stock Tanks Again as Trump Is Buried in Legal Troubles
The New Republic via Yahoo Finance· 3 days agoIn response, he was brutally mocked on Wall...revenue. The company is trading at just $42 per share,...
Nano Nuclear Energy Inc.’s (NASDAQ:NNE) Quiet Period To Expire on June 17th
ETF DAILY NEWS· 2 days agoNano Nuclear Energy’s (NASDAQ:NNE – Get Free Report) quiet period will end on Monday, June 17th....
GP-Act III Acquisition Corp.’s (NASDAQ:GPATU) Quiet Period Set To Expire on June 18th
ETF DAILY NEWS· 3 days agoGP-Act III Acquisition’s (NASDAQ:GPATU – Get Free Report) quiet period will end on Tuesday, June...
Could Meta Platforms Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 6 days agoMeta Platforms (NASDAQ: META) has been a fantastic investment historically. Despite bouts of...
Tempus AI prices US IPO at over $6 billion valuation
AOL· 8 hours agoThe genetics-testing company priced its IPO at the higher end of is targeted range of $35 to $37, valuing the firm at about $6.10 billion, based on the outstanding shares listed in its filing ...
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 7 days agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based ...
